Forbes
Cell, Gene And Specialty Drug Costs Intensify For Health Plans

Specialty drugs are an increasing worry for health plans and employers as new and innovative therapies enter the U.S. market and patients flock to them.
F
Source
Forbes
Read full article at Forbes
Opens original article in a new tab
Advertisement

